Mavala Mavamed
Natural health product licensed in Canada
- Other names
- MavaMED
- Licence holder
- Vanir Merchants Incorporated
- NPN or DIN-HM
- 80146063
- Status
- Active licence
- Licence date
- 11 December 2025
- Revision date
- Not provided
- Form
- Liquide topique
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Caproyle lactylate de sodium, Propylène glycol, d-limonène, Esters d'acide lactique et d'acide gras de glycérol, Glycérine, Huile essentielle de feuilles de Melaleuca alternifolia (Arbre à thé), Aqua, Huile de ricin hydrogénée de PEG-40, Poly(éthylène glycol) 450 tridécyl éther, Huile de feuilles d'Eucalyptus globulus, Gomme de xanthane, Extrait de Lavandula Angustifolia (Lavande), Alcool benzylique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Temporarily protects and helps relieve minor skin irritation and itching.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80146063
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.